Biosyent Incis A Specialty Pharmaceutical Company Focused On Improving Patient Lives By Sourcingacquiringand Developing Innovative Healthcare Productsoperating Primarily In Canada And Select International Marketsbiosyent Addresses Unmet Medical Needs Across Various Therapeutic Areasthe Company Is Publicly Traded On The Tsx Venture Exchange Under The Symbol Rx Biosyent S Product Portfolio Includes Combogesic For Pain Managementcathejell For Medical Proceduresand Several Oral Hematinics For Treating Iron Deficiency Anemiaamong Othersthe Company Emphasizes Core Values Such As Integrityrespectand Sustainabilitywhich Guide Its Business Practiceswith A Commitment To Identifying And Developing Effective Solutionsbiosyent Serves Healthcare Providers And Patients Seeking Specialized Pharmaceutical Products
